Helle Størum
Geen lopende functies
Profiel
Helle Størum worked as a Principal at H.
Lundbeck A from 2007 to 2016.
She then worked as a Director of Business Development at Zealand Pharma A from 2016 to 2017, and at Pharmacosmos A from 2017 to 2020.
She also worked as a Principal at Takeda A.
Currently, she is the Head of Business Development at Amniotics AB since 2020.
Ms. Størum holds a Master's degree in Business Administration from the University of Southern Denmark.
Eerdere bekende functies van Helle Størum
| Bedrijven | Functie | Einde |
|---|---|---|
| AMNIOTICS AB | Corporate Officer/Principal | 01-12-2023 |
Pharmacosmos A/S
 Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Corporate Officer/Principal | 01-01-2020 |
| ZEALAND PHARMA A/S | Directeur/Bestuurslid | 19-04-2016 |
| H. LUNDBECK A/S | Corporate Officer/Principal | 01-03-2016 |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Corporate Officer/Principal | - |
Opleiding van Helle Størum
| University of Southern Denmark | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ZEALAND PHARMA A/S | Health Technology |
| H. LUNDBECK A/S | Health Technology |
| AMNIOTICS AB | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Finance |
Pharmacosmos A/S
Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Health Technology |
